novo nordisk's semaglutide failed to slow alzheimer's disease progression Could diabetes and weight loss drugs treat disease? Semaglutide's Setback in Alzheimer Disease

Cleaning up

PMID 16246122

PT-141, also known as bremelanotide, is a centrally acting peptide therapy approved by the FDA for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women

While split dosing is a strategy used to reduce side effects for those who are highly sensitive, it is not the same as taking a full dose every five days

Zepbound (Tirzepatide) This powerful once-weekly injection enhances weight loss by targeting both GLP-1 and GIP hormones

Thyroid and cardiac concerns In phase 2 trials, 2-11% of patients receiving retatrutide experienced cardiac arrhythmias, compared with 2% in the placebo group